# A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

> **NCT03742518** · PHASE2,PHASE3 · COMPLETED · sponsor: **Biosplice Therapeutics, Inc.** · enrollment: 675 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** Topical SM04554 solution
- **DRUG:** Topical SM04554 solution
- **DRUG:** Topical vehicle solution

## Key facts

- **NCT ID:** NCT03742518
- **Lead sponsor:** Biosplice Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 675 (ACTUAL)
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03742518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03742518, "A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03742518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*